4//SEC Filing
WEST PHARMACEUTICAL SERVICES INC 4
Accession 0001225208-15-013127
$WSTCIK 0000105770operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 12:11 PM ET
Size
9.8 KB
Accession
0001225208-15-013127
Insider Transaction Report
Form 4
ANDERSON MICHAEL A
Vice President & Treasurer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2015-05-29$16.05/sh−2,000$32,090→ 7,000 totalExercise: $16.05From: 2010-02-24Exp: 2019-02-24→ Common Stock (2,000 underlying) - Sale
Common Stock
2015-05-29$54.44/sh−2,000$108,879→ 67,632.31 total - Exercise/Conversion
Common Stock
2015-05-29$16.05/sh+2,000$32,090→ 69,632.31 total
Holdings
- 909.824(indirect: By Savings Plan)
Common Stock
- 7,317.43(indirect: Non-Qualified Deferred Compensation Plan)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $54.41 to $54.48, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
Documents
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeoperating
IncorporatedPA
Related Parties
1- filerCIK 0000105770
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 12:11 PM ET
- Size
- 9.8 KB